NSE filing, NSE: LINCOLN. Summary written from the filing by ALFA Finder's alert engine.
Lincoln Pharmaceuticals Ltd: key numbers
- Share price
- ₹499.30
- Market cap
- ₹1,000 Cr
- Revenue (annual)
- ₹671.0 Cr
- Net profit (annual)
- ₹87.89 Cr
- P/E (TTM)
- 10.3×Sector 48.7×
- Promoter holding
- 49.78%+0.00% QoQ
- FII holding
- 4.55%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Lincoln Pharmaceuticals Ltd
All →Lincoln Pharmaceuticals Q2 FY27 Results: Net Profit ₹20.4 Cr, Up 2.0% YoY
Lincoln Pharmaceuticals Ltd reported revenue from operations of ₹191.3 Cr (+17.1% YoY) and net profit of ₹20.4 Cr (+2.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹20.4 Cr · +2.0% YoY
Lincoln Pharmaceuticals Board Meeting Date
Lincoln Pharmaceuticals intimated that its Board meeting is scheduled for 29 Oct 2026 to approve Q1/H1 2026 financial results. Trading window remains closed until 48 hours after results are published.
Lincoln Pharmaceuticals Other Announcement
Lincoln Pharmaceuticals Ltd has filed its quarterly shareholding pattern statement for the period ended September 30, 2026, as required under SEBI regulations.
Lincoln Pharmaceuticals Management Change
Lincoln Pharmaceuticals Ltd announced the resignation of Mr. Pradeep Kumar Yadav, Senior General Manager - Quality Assurance, effective October 17, 2026.
Lincoln Pharmaceuticals Annual General Meeting
Lincoln Pharmaceuticals submitted the minutes and voting results of its 32nd Annual General Meeting held on September 30, 2026. The meeting concluded successfully.
Lincoln Pharmaceuticals Annual General Meeting
Lincoln Pharmaceuticals held its 32nd Annual General Meeting on September 30, 2026, where shareholders considered financial statements, dividends, and director reappointments.
Other results correction announcements
All →Amalgamated Electricity Company Results Correction
Amalgamated Electricity revised its board outcome to correct a director's designation in the September 2026 balance sheet. The resubmission re-encloses the unaudited results and limited review report.
Manipal Payment and Identity Solutions Results Correction
Manipal Payment and Identity Solutions clarified two NSE observations on its 01 October 2026 financial results. It stated it has one operating segment and that the results PDF was machine-readable.
Tamilnad Mercantile Bank Results Correction
TMB clarified its ₹304.24 crore ECL provision is proactive, not a regulatory shortfall. The ECL framework applies from April 2027 under RBI rules.
Punjab National Bank Results Correction
Punjab National Bank re-submitted its unchanged September 2026 quarter and half-year results in machine-readable format. No figures, disclosures or other information were modified from the earlier filing.
Gateway Distriparks Results Correction
Gateway Distriparks issued a revised Q2 FY27 results press release to correct a typographical error in the earlier filing. The financial figures remain materially unchanged.
Padmanabh Alloys & Polymers Results Correction
Padmanabh Alloys revised its unaudited September 2026 quarter and half-year results to correct a deferred tax typing error. Profit, EPS and balance sheet figures are updated.